Tocagen, Forte Biosciences In Merger
socalTECH
FEBRUARY 20, 2020
San Diego-based Tocagen , which develops cancer-selective gene therapy aimted at treatking skin cancer, and Torrance-based Forte Biosciences , a biopharmaceuticals firm developing a live biotherapeutic for the treatment of inflammatory skin diseases, said on Wednesday that the two are in an agreement where Tocagen will merge with Forte in an all-stock (..)
Let's personalize your content